筛选
科学数据
统计数据
共检索到104条 ,权限内显示50条;
Data from: A quantitative electrophysiological biomarker of duplication 15q11.2-q13.1 syndrome
- 负责人：
- 关键词：
- Dup15q
- DOI：
- doi:10.5061/dryad.2th78
- 摘要：
- clinical trials. Future work will investigate the genetic and neural underpinnings of this electrophysiological signature as well as the functional
Data from: Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports
- 负责人：
- DOI：
- doi:10.5061/dryad.331f7
- 摘要：
- es representing 16 individuals). Compression factors ranged between 1 and 8805. Conclusions: Clinical study reports represent a hitherto mostly hidden and untapped
Data from: Effect of dimethyl fumarate on lymphocytes in RRMS: implications for clinical practice
- 负责人：
- DOI：
- doi:10.5061/dryad.n0cg254
- 摘要：
- ) treatment in patients with multiple sclerosis. Methods: Using peripheral blood from several clinical trials of DMF, immune cell subsets were quantified usi
Data from: Third wave cognitive therapy versus mentalization-based treatment for major depressive disorder: a randomised clinical trial
- 负责人：
- DOI：
- doi:10.5061/dryad.2d7h5
- 摘要：
- than mentalisation-based therapy for depressive symptoms measured on the HDRS. However, more randomised clinical trials are needed to assess the effect
Data from: Daridorexant, a new dual orexin receptor antagonist in elderly subjects with insomnia disorder: a randomized clinical trial
- 负责人：
- DOI：
- doi:10.5061/dryad.qnk98sfbw
- 摘要：
- mg) in elderly subjects with insomnia disorder. ClinicalTrials.gov (NCT02841709). Classification of Evidence: This study provides Class III evidence tha
Data from: Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis
- 负责人：
- DOI：
- doi:10.5061/dryad.3jd86nj
- 摘要：
- consistently revealed a rapid suppression of acute MRI and clinical disease activity following treatment initiation with ocrelizumab in patients with RRMS and R
Data from: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
- 负责人：
- 关键词：
- influenza;cochrane;neuraminidase inhibitor;clinical study reports;relenza;zanamivir;oseltamivir
- DOI：
- doi:10.5061/dryad.77471
- 摘要：
- in all age groups by reviewing all clinical study reports of published and unpublished randomised, placebo-controlled trials and regulatory comments
Data from: Preclinical toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and r
- 负责人：
- Lammens, Lieve
- DOI：
- doi:10.5061/dryad.5vv774m
- 摘要：
- of flubendazole administered with this formulation have been assessed to ensure human safety before clinical trials could be initiated. Methods &
Data from: Pooled analysis suggests benefit of catheter-based hematoma removal for intracerebral hemorrhage
- 负责人：
- DOI：
- doi:10.5061/dryad.vj2dj82
- 摘要：
- of randomized control trials and tested different interventions against the model at comparable baseline conditions. Eligible clinical trials and large case series wer
Data from: Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke
- 负责人：
- DOI：
- doi:10.5061/dryad.1s6s162
- 摘要：
- injury, and with clinical outcome. Results: Patients with IS had higher sNfL levels compared with HC starting from admission until 6 months post-stroke. sNfL levels peaked at day
